FOXO Stock Overview
Develops epigenetic biomarkers technology solutions in the United States. More details
Snowflake Analysis
Slight and slightly overvalued.
FOXO Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.084 |
52 Week High | US$1.30 |
52 Week Low | US$0.07 |
Beta | 3.52 |
1 Month Change | -47.07% |
3 Month Change | -63.43% |
1 Year Change | -68.50% |
3 Year Change | -99.92% |
5 Year Change | n/a |
Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
FOXO | US Software | US Market | |
---|---|---|---|
7D | -25.9% | -3.0% | -1.1% |
1Y | -68.5% | 1.2% | 5.9% |
Return vs Industry: FOXO underperformed the US Software industry which returned -0.1% over the past year.
Return vs Market: FOXO underperformed the US Market which returned 5.7% over the past year.
Price Volatility
FOXO volatility | |
---|---|
FOXO Average Weekly Movement | 16.5% |
Software Industry Average Movement | 8.9% |
Market Average Movement | 7.7% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 4.1% |
Stable Share Price: FOXO's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: FOXO's weekly volatility has decreased from 71% to 17% over the past year, but is still higher than 75% of US stocks.
Community vs My Fair Value
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | 4 | Seamus Lagan | foxotechnologies.com |
FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers.
FOXO Technologies Inc. Fundamentals Summary
FOXO fundamental statistics | |
---|---|
Market cap | US$3.01m |
Earnings (TTM) | -US$13.56m |
Revenue (TTM) | US$4.05m |
0.7x
P/S Ratio-0.2x
P/E RatioIs FOXO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FOXO income statement (TTM) | |
---|---|
Revenue | US$4.05m |
Cost of Revenue | US$2.48m |
Gross Profit | US$1.57m |
Other Expenses | US$15.13m |
Earnings | -US$13.56m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.38 |
Gross Margin | 38.68% |
Net Profit Margin | -334.72% |
Debt/Equity Ratio | 193.9% |
How did FOXO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/04/19 11:11 |
End of Day Share Price | 2025/04/17 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
FOXO Technologies Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.